Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$204.13 - $302.4 $1.08 Million - $1.6 Million
5,297 New
5,297 $1.31 Million
Q4 2021

Jan 20, 2022

SELL
$351.38 - $448.68 $1.21 Million - $1.54 Million
-3,430 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$372.64 - $458.3 $1.28 Million - $1.57 Million
3,430 New
3,430 $1.4 Million
Q1 2021

May 12, 2021

SELL
$249.67 - $299.48 $304,597 - $365,365
-1,220 Closed
0 $0
Q4 2020

Feb 04, 2021

BUY
$222.0 - $252.62 $270,840 - $308,196
1,220 New
1,220 $312,000
Q3 2020

Nov 02, 2020

SELL
$175.56 - $226.45 $421,344 - $543,480
-2,400 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$118.84 - $189.72 $285,216 - $455,328
2,400 New
2,400 $447,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.41B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sciencast Management LP Portfolio

Follow Sciencast Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Sciencast Management LP with notifications on news.